FDA chief urges ‘more dramatic action’ on opioids than past administrations

Published November 3, 2017 7:02pm ET



Food and Drug Commissioner Scott Gottlieb on Friday left the door open to the possibility of asking more drug companies to take their prescription opioids off the market.

Gottlieb, who has worked for the FDA in a leadership role under other administrations, said that he thought a stronger approach was needed to tackle the opioid epidemic than had been carried out during the last decade when he said federal agencies were aware the problem but failed to get ahead of it.

Already a print subscriber? Click here to login/register your account

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.